Rezolute (RZLT) Net Cash Flow (2010 - 2026)
Rezolute's (RZLT) quarterly Net Cash Flow came in at -$662000.0 in Q1 2026, down 111.69% year-on-year from $5.7 million in Q1 2025, and down 123.64% quarter-over-quarter from $2.8 million in Q4 2025.
Rezolute (RZLT) Net Cash Flow (2010 - 2026) Analysis & Trends
Rezolute has disclosed Net Cash Flow across 17 years of filings, most recently posting -$662000.0 for Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$662000.0, down 111.69% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 139.06% YoY), and the FY2025 annual result was $23.7 million, down 56.43% from the prior year.
- Net Cash Flow came in at -$662000.0 for Q1 2026 at Rezolute, down from $2.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $82.0 million in Q2 2022 to a low of -$113.0 million in Q1 2023.
- The 5-year median for Net Cash Flow is -$1.5 million (2024), against an average of -$4.2 million.
- Across the five-year window, Net Cash Flow surged 805.21% in 2022 and slumped 707.91% in 2023, its largest moves.
- Rezolute's Net Cash Flow stood at -$7.6 million in 2022, then jumped by 162.57% to $4.7 million in 2023, then sank by 132.49% to -$1.5 million in 2024, then soared by 281.82% to $2.8 million in 2025, then sank by 123.64% to -$662000.0 in 2026.
- The last three Net Cash Flow figures came in at -$662000.0 (Q1 2026), $2.8 million (Q4 2025), and -$85.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | -662,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -662,000.00 |
| Mar 31, 2026 | -662,000.00 |
| Dec 31, 2025 | 2.80 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | -85.01 Mn |
| Sep 30, 2025 | -85.01 Mn |
| Jun 30, 2025 | 79.49 Mn |
| Jun 30, 2025 | 79.49 Mn |
| Mar 31, 2025 | 5.66 Mn |
| Mar 31, 2025 | 5.66 Mn |
| Dec 31, 2024 | -1.54 Mn |
| Dec 31, 2024 | -1.54 Mn |
| Sep 30, 2024 | -59.92 Mn |
| Sep 30, 2024 | -59.92 Mn |
| Jun 30, 2024 | 64.47 Mn |
| Jun 30, 2024 | 64.47 Mn |
| Mar 31, 2024 | -6.57 Mn |
| Mar 31, 2024 | -6.57 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Dec 31, 2023 | 4.74 Mn |